ebook Munafa Stock Market Course + Intraday & FNO calls  

       

506235 announcements Alembic Ltd. announcements and dividends declared BSE

Alembic Ltd. Complete list of announcements declared & dividend announcements by Alembic Ltd. 506235

Alembic Ltd. 506235 listed on BSE and deals in

Announcements and dividends declared by Alembic Ltd. 506235

Alembic gets USFDA approval to market Clarithromycin tablets in America
Alembic's product is therapeutically equivalent to AbbVie Inc's Biaxin Filmtab Tablets, which is antimicrobial indicated to treat mild to moderate infections caused by designated, susceptible bacteria.
Announcement as on 01 February 2022

Alembic Pharmaceuticals gets USFDA nod to market generic product
Alembic Pharmaceuticals on Monday said it has received approval from the US health regulator to market generic Dronedarone tablets, which is used to reduce risk of hospitalisation for atrial fibrillation, in the American market. The company has received te
Announcement as on 10 January 2022

Alembic Pharma gets tentative USFDA approval for depressive disorder drug
Alembic Pharmaceuticals Ltd on Friday said it has received tentative approval from the US health regulator for its generic Vortioxetine tablets indicated for the treatment of the major depressive disorder. The tentative approval granted by the US Food & Dr
Announcement as on 08 January 2022

Alembic Pharma gets tentative USFDA approval for depressive disorder drug
Citing IQVIA data, the company said these Vortioxetine tablets have an estimated market size of USD 1,249 million for twelve months ending September 2021. Alembic, however, said it is currently in litigation with H Lundbeck in the Court of appeals for the
Announcement as on 07 January 2022

Alembic Pharma gets USFDA nod for generic drug to treat Parkinson's disease
Alembic Pharmaceuticals on Thursday said it has received final approval from the US health regulator for its generic Entacapone tablets indicated for patients with Parkinson's disease. The approval by the US Food & Drug Administration (USFDA) for the abbre
Announcement as on 06 January 2022

Announcements by Alembic Ltd. first page | Next page | Prev page |

506235 Alembic Ltd. current price & indicator signals

Moving Averages for Alembic Ltd.

  • 5Day Average: 87.61
  • 12Day Average: 89.22
  • 20Day Average: 90.69
  • 50Day Average: 86.38
  • 100Day Average: 90.67
  • 150Day Average: 93.87
  • 200Day Average: 96.64

506235 Indicators & signals

Indicator MACD (12,26,9)

89.03, 89.29, 0.44
Indicator MACD is in negative zone

Indicator ADX (14)

11.54, 19.09, 24.07
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 49
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 506235 Alembic Ltd. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
26 Tue May 2026 88.01 87.65 to 88.88 0.32% 1.26 times
25 Mon May 2026 87.73 87.13 to 89.40 0.31% 1.1 times
22 Fri May 2026 87.46 87.11 to 88.85 0.09% 0.78 times
21 Thu May 2026 87.38 87.00 to 89.20 -0.13% 0.87 times
20 Wed May 2026 87.49 86.80 to 88.51 -2.75% 0.82 times
19 Tue May 2026 89.96 88.00 to 91.00 1.67% 1.31 times
18 Mon May 2026 88.48 86.88 to 90.38 -1.49% 0.66 times
15 Fri May 2026 89.82 89.70 to 92.00 -1.75% 1.05 times
14 Thu May 2026 91.42 90.00 to 91.74 1.6% 0.76 times
13 Wed May 2026 89.98 89.06 to 90.70 -0.48% 1.23 times
12 Tue May 2026 90.41 90.05 to 92.84 -2.28% 1.42 times
11 Mon May 2026 92.52 92.00 to 93.93 -2.55% 2.29 times

Videos related to: 506235 announcements Alembic Ltd. announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

506235 announcements Alembic Ltd. announcements and dividends declared BSE

 

Back to top